Improvement of long-term prognosis in patients with ovarian cancers by adjuvant sizofiran immunotherapy: a prospective randomized controlled study
Biotherapy · 1993
DOI: 10.1007/bf01877381 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Biotherapy, 1993. Verfasst von M Inoue und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Osaka University Medical School. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Osaka University Medical School.
Zitieren
APA
Inoue, M., Tanaka, Y., Sugita, N., Yamasaki, M., Yamanaka, T., Minagawa, J., Nakamuro, K., Tani, T., Okudaira, Y., & Karita, T. (1993). Improvement of long-term prognosis in patients with ovarian cancers by adjuvant sizofiran immunotherapy: a prospective randomized controlled study. Biotherapy. https://doi.org/10.1007/bf01877381
Vancouver
Inoue M, Tanaka Y, Sugita N, Yamasaki M, Yamanaka T, Minagawa J, et al. Improvement of long-term prognosis in patients with ovarian cancers by adjuvant sizofiran immunotherapy: a prospective randomized controlled study. Biotherapy. 1993. doi:10.1007/bf01877381
BibTeX
@article{Inoue1993,
author = {Inoue, M and Tanaka, Y and Sugita, N and Yamasaki, M and Yamanaka, T and Minagawa, J and Nakamuro, K and Tani, T and Okudaira, Y and Karita, T},
title = {Improvement of long-term prognosis in patients with ovarian cancers by adjuvant sizofiran immunotherapy: a prospective randomized controlled study},
journal = {Biotherapy},
year = {1993},
doi = {10.1007/bf01877381}
}
EUVIMED